HitGen Inc. announced that the company has successfully completed the multiple-target drug discovery research projects with UPPTHERA. During the collaboration, multiple undisclosed targets were screened against HitGen's proprietary over 1 trillion DNA-encoded libraries (DELs). The majority of the targets have resulted in confirmed hits, which have high potential for PROTAC development.

Now the two parties are extending the collaboration on further development of these projects and additional challenging targets.